Merck demonstrates excellence across the board through its resilient revenue mix, expanding profitability, and stellar ...
Pharmaceutical Technology on MSN
Merck KGaA eyes new Parkinson’s disease assets with $3bn Valo partnership
Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.
Merck KGaA has given Orange Business Services responsibility for redesigning its global computer network. The agreement tasks Orange with making Merck KGaA’s network infrastructure less complex, while ...
StockStory.org on MSN
Q3 Earnings Outperformers: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Merck has bullish valuation metrics and is trading above its 30-week EMA with bullish long-term momentum. Learn why MRK stock ...
No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees. By that ...
Merck headquarters in Rahway, NJ. RAHWAY, N.J.- Merck has completed its $10 billion buyout of the British biopharmaceutical company Verona. The deal was first announced in July. It brings the chronic ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
Merck’s MRK shares have risen almost 13% in the past week as Pfizer’s PFE landmark deal with the Trump administration to lower drug costs eased investor concerns over pricing and tariffs in the pharma ...
U.S. pharma giant Merck is shuttering its Covid-19 vaccine program and will shift its focus to advancing two treatments for the disease after early results from clinical trials showed both vaccines it ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results